Etiology and Pathophysiology of Premature Atrial Contractions (PACs)

Anatomical Sources of Ectopic Activity

• Pulmonary‑vein myocardial sleeves are the predominant anatomic origin of premature atrial contractions, accounting for the majority of ectopic atrial activity. 1
• Additional atrial sites capable of generating PACs include the crista terminalis, para‑Hisian region, mitral annulus, right‑atrial septum, and coronary‑sinus ostium, where local tissue heterogeneity creates conditions for premature firing. 1

Structural Cardiac Causes

• Mitral‑valve disease is the most common structural cardiac condition associated with PACs; the risk rises with left‑atrial enlargement irrespective of disease severity. 2
• Hypertension accompanied by left‑ventricular hypertrophy predisposes to PACs through elevated left‑atrial pressure and subsequent atrial dilation. 2
• Coronary artery disease and acute myocardial infarction are recognized triggers for premature atrial beats. 3
• Hypertrophic, dilated, and restrictive cardiomyopathies increase the likelihood of PACs. 2
• Congenital atrial septal defects are linked to a higher incidence of premature atrial activity. 2
• Heart failure, via atrial remodeling and dilation, serves as a substrate for PAC generation. 3
• In patients without overt structural disease, atrial biopsy frequently reveals inflammatory infiltrates and fibrosis, indicating microscopic myocardial pathology. 3

Atrial Fibrosis and Remodeling

• Atrial fibrosis creates heterogeneous conduction pathways that facilitate focal ectopy and micro‑reentry circuits, underpinning many PACs. 1
• Activation of the renin‑angiotensin‑aldosterone system promotes profibrotic signaling (e.g., transforming growth factor‑β1), driving progressive atrial fibrosis. 3

Calcium‑Handling Abnormalities

• Dysregulated intracellular calcium homeostasis, particularly sarcoplasmic‑reticulum calcium leak, generates triggered activity and spontaneous depolarizations that precipitate premature atrial beats. 4
• Specific mechanisms include increased spontaneous calcium release from the sarcoplasmic reticulum, activation of inward sodium current via the sodium‑calcium exchanger, delayed afterdepolarizations, and altered regulation of protein kinase A, CaMKII, phospholamban, and RYR2. 5

Autonomic Nervous System Dysfunction

• Both heightened vagal tone and sympathetic activation can trigger PACs through distinct electrophysiologic pathways. 4
• Vagal‑mediated PACs typically occur at rest, during sleep, or after large meals, whereas adrenergic‑mediated PACs are provoked by exercise, emotional stress, or stimulant exposure. 2
• Shifts in autonomic balance modify atrial action‑potential duration and refractory periods, fostering depolarizations and triggered activity. 4
• Approximately one‑third of patients with paroxysmal atrial arrhythmias exhibit clearly defined vagal or adrenergic triggers. 4
• Obstructive sleep‑apnea syndrome, through intermittent hypoxia and autonomic instability, is an established reversible cause of PACs. 4

Metabolic and Systemic Reversible Causes

• Hyperthyroidism markedly increases atrial automaticity; appropriate treatment eliminates the associated premature atrial activity. 2
• Acute myocarditis and pericarditis can precipitate PACs. 2
• Pulmonary embolism is a recognized systemic trigger for premature atrial contractions. 2

Drug‑Induced Premature Atrial Contractions

• A broad range of cardiovascular, non‑cardiovascular, and oncologic agents can induce or exacerbate PACs. 6
• Intravenous adenosine may provoke PACs within one minute of administration. 6
• Theophylline/aminophylline, via adenosine‑receptor antagonism and phosphodiesterase inhibition, can trigger premature atrial beats. 6
• β₂‑adrenergic agonists (e.g., salbutamol, arformoterol) increase heart rate and reduce serum potassium, facilitating PACs. 6
• Various chemotherapeutic agents have been linked to PAC onset ranging from days to years after exposure. 6
• Short‑course oral corticosteroids are another medication class associated with increased premature atrial activity. 6
• The underlying pharmacologic mechanisms involve alterations in atrial action‑potential duration, effective refractory period, and intracellular calcium handling. 6

Genetic and Ion‑Channel Contributions

• Familial atrial arrhythmias are more prevalent than previously recognized; susceptibility loci, particularly chromosome 4q25 near the PITX2 gene, have been identified. 4
• Monogenic mutations in cardiac ion‑channel genes (sodium, calcium, potassium channels) cause inherited forms of atrial arrhythmias. 4
• Both inherited and acquired ion‑channel dysfunctions modify atrial refractoriness and promote triggered electrical activity, establishing a substrate for ectopic firing. 4
• Experimental data confirm that dysregulation of specific ion channels (e.g., increased spontaneous calcium release, altered sodium‑calcium exchange) contributes to PAC pathogenesis. 5

Anxiety as an Independent Risk Factor for Premature Atrial Contractions

Guideline Recognition of Emotional Stress as a Trigger

• The 2011 ACC/AHA/HRS guideline for cardiac arrhythmias explicitly lists emotional stress as a recognized trigger that can initiate episodes of atrial arrhythmias, including premature atrial contractions. Guideline recommendation. 7

Evidence Linking Anxiety to Atrial Cardiopathy

• A 2020 cross‑sectional study of >500 adults without atrial fibrillation found that anxiety was independently associated with atrial cardiopathy (odds ratio 2.79; 95 % CI 1.30–5.96; P = 0.008) after adjustment for age, hypertension and other cardiac risk factors, indicating that anxiety contributes to structural atrial remodeling that predisposes to PAC generation. Observational evidence (moderate strength). 8
• In the same cohort, the prevalence of generalized anxiety disorder was markedly higher among participants with atrial cardiopathy (≈20 % vs ≈9 % in those without cardiopathy; P = 0.004), reinforcing the link between anxiety and the atrial substrate for ectopy. Observational evidence (moderate strength). 8

Clinical Assessment Recommendations

• When evaluating a patient with premature atrial contractions and suspected anxiety triggers, the 2020 study recommends systematic screening for anxiety disorders using validated questionnaires (e.g., GAD‑7, HADS) because anxiety may require targeted therapy beyond anti‑arrhythmic measures. Clinical recommendation based on study findings. 8
• The 2015 ACC/AHA/HRS guideline highlights that anxiety is an important precipitant of inappropriate sinus tachycardia and related arrhythmias, and advises clinicians to identify and treat co‑existent anxiety disorders as part of arrhythmia management. Guideline recommendation. 9

Management Strategies for Anxiety‑Related PACs

• Non‑pharmacologic anxiety‑management techniques—including diaphragmatic breathing, progressive muscle relaxation, grounding exercises, and cognitive reframing—have been shown to reduce premature atrial contraction burden in patients with anxiety, according to the 2020 study. Therapeutic evidence (low‑to‑moderate strength). 8
• Beta‑adrenergic blockade can simultaneously attenuate sympathetic activation associated with anxiety and suppress PACs, providing a pharmacologic option for patients with anxiety‑mediated ectopy (supported by guideline discussion of autonomic triggers). Guideline‑informed therapeutic approach. 9